Toxicology & Substance Use · Topic 14 of 17
Malignant Hyperthermia
Malignant Hyperthermia
An inherited hypermetabolic crisis under anesthesia: stop the volatile agent, hyperventilate with 100% oxygen, and give dantrolene 2.5 mg/kg IV.
MH is an inherited (autosomal dominant, usually RYR1 ryanodine-receptor) skeletal-muscle reaction to potent volatile anesthetics (sevoflurane, desflurane, isoflurane, halothane) and succinylcholine; it may follow the first exposure but averages 3.
Suspect MH when rising end-tidal CO₂ despite increased minute ventilation, jaw (masseter) rigidity and tachycardia appear 10 minutes to several hours into inhalational anesthesia; hyperthermia (often ≥ 40 °C) and acidosis follow.
Give dantrolene 2.5 mg/kg IV rapidly, repeated as often as needed until end-tidal CO₂, rigidity and heart rate fall; if > 10 mg/kg brings no response, reconsider the diagnosis.
Diagnosis & monitoring
Work-upDo right now
In this orderWhy each step
Management
OrdersRed flags & don'ts
Avoid harmThe rules
Know theseMalignant hyperthermia or NMS?
Commonly confused| Trigger | Volatile anesthetic or succinylcholine |
|---|---|
| Onset | Minutes to hours after anesthesia starts |
| First clue | Rising end-tidal CO₂, jaw rigidity |
| Cause | Inherited (usually RYR1), autosomal dominant |
Commonly confused
Tell apartMore detail
ReferenceShow 5 reference facts
A rising end-tidal CO₂ despite more ventilation is the early alarm — give dantrolene early, not after the fever.
Sources · Merck Manual Professional — Malignant Hyperthermia (May 2025) · MHAUS — Managing a Crisis: Emergency Treatment for an Acute MH Event · MHAUS — Post Acute Phase: Management in PACU or ICU · Merck Manual Professional — Neuroleptic Malignant Syndrome (Nov 2025) · Rosenberg H, Pollock N, Schiemann A, et al. Malignant hyperthermia: a review. Orphanet J Rare Dis 2015;10:93 · Starter sheet built from the verified AGACNP fact map (facts reviewed 2026-10-15).